Skip to content
Winfred
Back to Investors
CI

CN Innovations

Other

CN Innovations Group is an advanced manufacturing and material science company headquartered in Hong Kong, offering technical and supply chain solutions.

Website

Portfolio

1

companies

By category

  • BioTech£17.0M

By location

  • Cambridge£17.0M

Portfolio companies

CN Bio

CN Bio

CN Bio develops advanced Organ-on-a-Chip systems to transform human-relevant drug discovery.

Team

CC

Charles Chong

Managing Director

HC

HS Chong

Founder

BC

Bob Chong

Founder

Recent investments

Series B
£17.0M

CN Bio raises £17m in Series B funding from Bayland Capital and CN Innovations to scale operations

CN Bio
BioTechHealthTechMedTech

The financing round was backed by Bayland Capital and founding shareholder CN Innovations to accelerate product development and commercial expansion.

"We are seeing pivotal growth across our industry, whereby drug developers are increasingly recognising the potential of OOC technology to augment, supplement and optimize their workflows."
— Paul Brooks, CEO
CN Bio
CN Bio— Cambridge, UK
Bayland Capital
CI
Bayland Capital + 1 other